CASP8 Is a Potential Therapeutic Target and Is Correlated with Pyroptosis in Traumatic Brain Injury

Gengshui Zhao1, Yongqi Fu2, Chao Yang3

  • 1Department of Neurosurgery, The People's Hospital of Hengshui City, Hengshui, China.

World Neurosurgery
|March 9, 2023
PubMed
Abstract

Insights

This study identifies Caspase 8 (CASP8) as a key molecular link between traumatic brain injury (TBI) and pyroptosis. Targeting CASP8 may offer new therapeutic strategies for TBI patients.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Traumatic brain injury (TBI) is a significant cause of long-term neurological and psychological disability.
  • Understanding the molecular mechanisms underlying TBI is crucial for developing effective treatments.
  • Pyroptosis, a programmed cell death pathway, is implicated in various inflammatory conditions.

Purpose of the Study:

  • To explore the molecular mechanisms linking TBI and pyroptosis.
  • To identify potential therapeutic targets for TBI.
  • To investigate the role of Caspase 8 (CASP8) in TBI pathogenesis.

Main Methods:

  • Utilized the GSE104687 microarray dataset to identify differentially expressed genes in TBI.
  • Screened pyroptosis-related genes from the GeneCards database.
  • Performed immune infiltration analysis, miRNA, and transcription factor analysis.
  • Validated findings using a validation set and in vivo experiments.

Main Results:

  • Identified Caspase 8 (CASP8) as the overlapping gene between TBI and pyroptosis.
  • Observed significantly higher Treg cell abundance in the TBI group.
  • Found positive correlations between CASP8 expression and NKT and CD8+ Tem cells.
  • Linked CASP8 to the NF-kappaB signaling pathway, further supported by miRNA analysis.

Conclusions:

  • Caspase 8 (CASP8) plays a potential role in the pathogenesis of TBI.
  • CASP8 may serve as a novel therapeutic target for TBI.
  • Findings could inform individualized therapy and drug development for TBI.